Trial Profile
Additional Effect of a Life Style Program on Antihypertensive Treatment With Telmisartan.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2014
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Telmisartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 29 Aug 2012 Primary endpoint 'Systolic-blood-pressure' has not been met according to results presented at the ESC Congress 2012.
- 29 Aug 2012 Primary endpoint 'Diastolic-blood-pressure' has not been met according to results presented at the ESC Congress 2012.
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.